SCHEMBL29212741

SCHEMBL29212741

CC(C)(C)OC(=O)Nc1c(I)ccc(Br)c1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.39
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ RECQL P46063 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ SSTR4 P31391 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ LCK P06239 4/20 0.34
▸ AAK1 Q2M2I8 3/20 0.34
▸ CTSS P25774 2/20 0.33
▸ CTSK P43235 2/20 0.33
▸ CYP17A1 P05093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30896204 1.00 ATR (0.39) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL6523050 0.85 ATR (0.40) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL30038713 0.84 CYP17A1 (0.40) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL28459659 0.84 CYP17A1 (0.40) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL22684078 0.78 CYP17A1 (0.38) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL24427976 0.78 CYP17A1 (0.42) NPC1RAB9AMEN1KMT2AHTT
SCHEMBL660566 0.77 NLRP3 (0.43) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL439559 0.76 LMNA (0.44) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL30710105 0.75 LCK (0.42) ATRNPC1RAB9AMEN1KMT2A
SCHEMBL26694465 0.75 LCK (0.42) ATRNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119948029-A Fused tricyclic PARP1 inhibitor, preparation method and application thereof 上海海和药物研究开发股份有限公司 2025-05-06 — — CN disclosed
CN-118005637-A Fused tricyclic PARP1 inhibitor, preparation method and application thereof 上海海和药物研究开发股份有限公司 2024-05-10 — — CN disclosed
Send feedback